Malaysia's National Anti-Drug Agency (Nada/AADK) will begin deploying specialized test kits across the country in June to detect fentanyl and emerging synthetic drugs amid rising enforcement challenges [1, 2, 3, 4].
The kits, which have already been distributed to all agency offices nationwide, can identify fentanyl, synthetic cannabinoids, cocaine, and psilocybin, the psychoactive compound found in magic mushrooms [1, 2, 3, 4]. Datuk Ruslin Jusoh, Nada's director-general, said, "Previously, there were claims that Nada could not test for fentanyl and synthetic substances. We now have the equipment, and it has already been distributed nationwide. Beginning June, we will start conducting tests during operations using these kits, particularly for fentanyl and synthetic cannabinoids" [2].
Synthetic drugs, especially those mixed into vape liquids, pose a new enforcement and rehabilitation challenge in Malaysia. Datuk Ruslin added, "Scientifically, magic mushrooms are fungi containing psilocybin. However, most cases we detected locally actually involved synthetic cannabinoids, or synthetic cannabis, usually in liquid form" [2]. The agency has not yet confirmed any fentanyl abuse cases among detainees or those undergoing rehabilitation [2, 3].
Polydrug abuse involving fentanyl, synthetic cannabinoids, and other substances can cause severe effects such as hallucinations, suicidal tendencies, and erratic behavior [2, 3]. Synthetic drug addiction currently accounts for about 70% of all drug addiction cases in Malaysia [4].
In the first five months of 2026 alone, about 15,000 individuals were detained for drug-related offenses nationwide [4]. The agency aims for a total of 40,000 drug-related arrests this year based on intelligence and public reports [4]. To aid in enforcement, the National Anti-Drug Agency has also established a drone unit [4].
Starting in June, Nada plans operational use of the test kits to screen for fentanyl, synthetic cannabinoids, and cocaine, particularly those found in vape liquids [4]. This rollout marks a significant step in addressing the rising threat of synthetic drugs in Malaysia.
